← Back to all trials
Active Not Recruiting
NCT07676539
Adapting the STRW Intervention for Adolescents and Young Adults With Epilepsy (ARGOS)
Conditions: Epilepsy, Epilepsy in Youth, Activities, Daily Living
Sex: All
Ages: 14 Years – 19 Years
Healthy volunteers: No
Phase: NA
Enrollment: 8
Sponsor: Children's Hospital Medical Center, Cincinnati
Location: Cincinnati Children's Hospital Medical Center Cincinnati Ohio
Summary
The goal of this clinical trial is to learn if a telehealth intervention (Surviving and Thriving in the Real World; STRW) is helpful to improve daily living skills for teens and young adults with epilepsy. It will also learn about the acceptability, feasibility, and satisfaction of the intervention. The main questions it aims to answer are:
* Is STRW an acceptable, feasible, and satisfactory intervention for teens/young adults and their caregivers?
* Does STRW improve daily living skills (e.g., cooking, laundry, money management) for teens and young adults with epilepsy?
This is a nonrandomized pilot trial and all participants who enroll will:
* Participate in weekly caregiver/teen dyads ( approximately 60 minutes) focused on improving daily living skills with a trained therapist for 15 weeks.
* Participate in weekly caregiver groups (approximately 90 minutes) focused on supporting caregivers in coaching their teens in daily living skills development led by 2 trained therapists for 14 of the 15 intervention weeks.
* Complete measures of adaptive functioning (to evaluate daily living skills; parent and teen-report) at the start of the study and post-intervention. Additional measures will also be collected.
* Have the option to complete post-intervention interviews to provide feedback on the intervention components.
Eligibility Criteria
Inclusion Criteria:
1. diagnosed with epilepsy at least 1 year ago,
2. enrolled in 9th-12th grade (i.e., 14-18 years old at time of enrollment)
3. deficits in adaptive functioning per caregiver report (i.e., standard score below 90 on either the ABAS-3 Practical Domain or General Adaptive Composite \[GAC\]),
4. not planning to wean off anti-seizure medication (ASM) within the intervention timeframe,
5. and family's primary language is English.
Exclusion Criteria:
1. Parent- or clinician-reported history in the adolescent/young adult of:
1. history of developmental delay (e.g., autism spectrum disorder, pervasive development disorder, history of services for developmental delay or intellectual impairment in the past 5 years, known IQ\
Source: ClinicalTrials.gov (NCT07676539). StuddyBuddy aggregates publicly available trial information.